(Q34294096)

English

Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Beta-sitosterol Study Group

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Beta-sitosterol Study Group (English)

1 reference

Europe PubMed Central

1 August 2017

0 references

0 references

beta-sitosterol

1 reference

based on heuristic

inferred from title

double-blind clinical trial

1 reference

based on heuristic

inferred from title

author name string

R R Berges

1

1 reference

Europe PubMed Central

1 August 2017

J Windeler

2

1 reference

Europe PubMed Central

1 August 2017

H J Trampisch

3

1 reference

Europe PubMed Central

1 August 2017

T Senge

4

1 reference

Europe PubMed Central

1 August 2017

language of work or name

0 references

publication date

1 June 1995

1 reference

Europe PubMed Central

1 August 2017

number of pages

4

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

1 August 2017

345

1 reference

Europe PubMed Central

1 August 2017

8964

1 reference

Europe PubMed Central

1 August 2017

1529-1532

1 reference

Europe PubMed Central

1 August 2017

The development of human benign prostatic hyperplasia with age

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991085-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The incidence of benign prostatic obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991085-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Symptom status and quality of life following prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991085-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Finasteride (MK-906) in the treatment of benign prostatic hyperplasia. The Finasteride Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991085-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A Placebo-controlled Double-blind Study of the Effect of Phenoxybenzamine in Benign Prostatic Obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991085-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Alfuzosin for treatment of benign prostatic hypertrophy. The BPH-ALF Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991085-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Doxazosin treatment in patients with prostatic obstruction. A double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991085-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A three month double-blind study of doxazosin as treatment for benign prostatic bladder outlet obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991085-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(95)91085-9

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34294096&oldid=1982343164"